BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 32 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $12,912,000 | +14.2% | 9,800,000 | -7.5% | 0.00% | 0.0% |
| Q1 2020 | $11,304,000 | -15.5% | 10,600,000 | -13.8% | 0.00% | 0.0% |
| Q4 2019 | $13,383,000 | +7.4% | 12,300,000 | +2.5% | 0.00% | 0.0% |
| Q3 2019 | $12,462,000 | -3.7% | 12,000,000 | +4.3% | 0.00% | 0.0% |
| Q2 2019 | $12,940,000 | +13.8% | 11,500,000 | +15.6% | 0.00% | 0.0% |
| Q1 2019 | $11,373,000 | -16.7% | 9,950,000 | -18.8% | 0.00% | 0.0% |
| Q4 2018 | $13,645,000 | -14.6% | 12,250,000 | -7.5% | 0.00% | 0.0% |
| Q3 2018 | $15,975,000 | +3.3% | 13,250,000 | +1.5% | 0.00% | 0.0% |
| Q2 2018 | $15,466,000 | +20.4% | 13,050,000 | +13.0% | 0.00% | 0.0% |
| Q1 2018 | $12,850,000 | -6.4% | 11,550,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $13,730,000 | -2.6% | 11,550,000 | -0.9% | 0.00% | 0.0% |
| Q3 2017 | $14,099,000 | – | 11,650,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |